Both are leading GLP-1-based weight-loss treatments, but they don't work in exactly the same way. Here's a clear, balanced comparison of how they differ, and what that means for you.
Semaglutide acts on a single hormone pathway (GLP-1). Tirzepatide acts on two pathways at once (GLP-1 and GIP), which is why it's often described as a "dual-action" treatment. Both reduce appetite and support weight loss; tirzepatide is newer and works through an additional mechanism.
Key point: Neither is universally "better." Which is more appropriate depends on your health profile, history, and how your body responds, something only a licensed physician can determine.
Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a hormone your gut naturally releases after eating. By amplifying that signal, it reduces appetite, slows digestion, and helps you feel full sooner and for longer. It's the active ingredient in several well-known brand-name medications and is also available in compounded form through many telehealth programs.
Tirzepatide is a dual-action treatment. In addition to acting on the GLP-1 receptor like semaglutide, it also acts on the GIP (glucose-dependent insulinotropic polypeptide) receptor. This second pathway is thought to contribute to its effects on appetite and metabolism. Because it engages two receptors rather than one, some people respond differently to it than to semaglutide.
Both medications are typically delivered as a once-weekly injection, both are titrated (gradually increased) under medical supervision, and both can cause similar early side effects, most commonly mild gastrointestinal symptoms that tend to ease over time.
This is genuinely a medical decision, not a marketing one. A licensed physician weighs factors such as your medical history, other medications, how you tolerate treatment, and your goals. Some programs offer both options and adjust based on how you respond. The most important thing is that a qualified provider reviews your situation before anything is prescribed.
Important: Don't choose a medication based on internet comparisons alone. Use this as background to have a more informed conversation with the provider who reviews your case.
The programs we match you to include a physician review that helps determine the right treatment for your situation. Our quiz finds your fit in 60 seconds.
Take the QuizClinical research suggests tirzepatide can produce greater average weight loss for many people, but results vary by individual. "More effective on average" is not the same as "better for you specifically", tolerability and your health profile matter just as much. A physician can advise based on your case.
The side-effect profiles are broadly similar, most commonly mild gastrointestinal symptoms (nausea, reduced appetite) in the early weeks as the dose is increased. Your prescribing physician monitors this and adjusts accordingly.
Many telehealth programs offer both semaglutide and tirzepatide options, in brand-name or compounded forms. Availability and pricing differ by program, our cost guide explains what affects the price.
Answer four quick questions and we'll match you to a LegitScript-certified program whose physicians can help determine the right treatment for you.
Take the Quiz, 60 Seconds